Welcome to the First 2020 Issue of The CLL Society Tribune
Dear Friends and Supporters of the CLL Society,
In these days of COVID-19 it is helpful to remain calm and remember that this, too, shall pass. Directing awareness towards “the helpers” in our CLL journey is a good place to focus attention and will position us in good stead.
Dr. Koffman’s “Did You Know? Coronavirus Edition” in this issue of the CLL Tribune offers a handful of basic information currently known about COVID-19.
Deb Kirkland alerts us to “Patient navigators” who can significantly shortcut patients’ access to beneficial services.
Writer Joe A. meticulously charts his own health history and doesn’t wait for “medical records” to make the introduction to or inform his new HCP. Will you emulate this?
Pharmacist Tom Henry gives a thorough run-through on acalabrutinib (Calquence®).
Dr. Chaitra Ujjani will investigate “fixed duration” therapy in her upcoming Veneto-Stop clinical trial.
Our ever-popular “Ask the Experts” columns bring answers to your questions.
We would like to thank Therese Conlin for helping us proof-read these articles.
During COVID-19 we newly appreciate the enduring value of the lessons we learned in Kindergarten: Wash your hands, don’t touch your face, give others space.
If you or a loved one has been helped by the CLL Society, please consider making a donation.
Thank you and be well!
Dr. Koffman introduces this New York Times story set in 2003 when there were no treatment options for CLL. … Read more
CLL Tribune is looking for your contribution including articles, storytelling, poems, drawings, or other creative mediums. Please share!
Email firstname.lastname@example.org with your interest!
By Brian Koffman, MD
At the ASH 2019 meeting, in Orlando, Florida in December, we discussed the important Veneto-STOP trial that examines the best time to stop venetoclax when treating chronic lymphocytic leukemia. … Watch The Interview
By Richard Furman, MD
Dr. Richard Furman of Weill-Cornell Medical College answers readers’ questions submitted to the CLL Society…Read more
Thomas E Henry III, MBA, RPh, CPh from Burlington Consulting Associates answers readers’ pharmacy questions submitted to the CLL Society…Read more
Susan J. Leclair from University of Massachusetts Dartmouth answers readers’ lab scientist questions submitted to the CLL Society…Read more
Dr. Ratner at the Minneapolis VA Medical Center answers readers’ hospice/palliative care questions submitted to the CLL Society…Read more
The CLL Society Tribune is made possible in part by grant support from AbbVie, Genentech, and Astra Zeneca
The CLL Society does not provide medical advice or endorsements. Unless explicitly stated otherwise, all content in the CLL Tribune is the opinion or information of its author, not the CLL Society. This newsletter is for reference and educational purposes only and is not a substitute for medical advice. We do not guarantee the accuracy of any of the materials. Always contact your own doctor or other professional healthcare provider if you have any questions concerning your or your family’s health. Everyone’s circumstances are different.